Serum Institute of India (SII) CEO Adar Poonawalla offloaded his complete stake in Panacea Biotec in a block deal on Monday. He had a 5.15 per cent shareholding within the agency, which amounted for over Rs 118 crore and have been picked by SII.
Poonawalla offered 31,57,034 shares of Panacea Biotec at a value of Rs 373.85 apiece, information accessible on the BSE confirmed. The complete worth of the transaction was a bit of over Rs 118 crore (Rs 1,18,02,57,160.90).
His firm SII picked the shares on the identical value, the BSE information confirmed.
As per shareholding information for March quarter, each Poonawalla and SII have been public shareholders within the agency and held 5.15 per cent and 4.98 per cent stake respectively in Panacea Biotec, information company PTI reported.
The Panacea Biotec inventory on Monday had ended at Rs 384.90 apiece, up 1.16 per cent from the earlier shut.
